{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:37:39Z","timestamp":1793025459595,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002842","name":"Chiang Mai University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002842","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010731","name":"Chiang Mai University Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.yexmp.2026.105091","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:28:07Z","timestamp":1792265287000},"page":"105091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Serum peptidome signatures as diagnostic biomarkers of lung cancer: A systematic review"],"prefix":"10.1016","volume":"148","author":[{"given":"Sutpirat","family":"Moonmuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhasiri","family":"Orrapin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasimol","family":"Udomruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petlada","family":"Yongpitakwattana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammaraluk","family":"Kovavisarach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dumnoensun","family":"Pruksakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apichat","family":"Tantraworasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parunya","family":"Chaiyawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.yexmp.2026.105091_bb0005","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","article-title":"The human plasma proteome: history, character, and diagnostic prospects","volume":"1","author":"Anderson","year":"2002","journal-title":"Mol. Cell. Proteomics"},{"issue":"5","key":"10.1016\/j.yexmp.2026.105091_bb0010","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1080\/10408347.2021.2001309","article-title":"Reactive matrices for analytical matrix-assisted laser desorption\/ionization (MALDI) mass spectrometry","volume":"53","author":"Borisov","year":"2023","journal-title":"Crit. Rev. Anal. Chem."},{"issue":"4","key":"10.1016\/j.yexmp.2026.105091_bb0015","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/ab2f9f","article-title":"Exhaled breath condensate biomarkers for lung cancer","volume":"13","author":"Campanella","year":"2019","journal-title":"J. Breath Res."},{"issue":"4","key":"10.1016\/j.yexmp.2026.105091_bb0020","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.21037\/tlcr-20-148","article-title":"Mass spectrometry-based serum proteomic signature as a potential biomarker for survival in patients with non-small cell lung cancer receiving immunotherapy","volume":"9","author":"Chae","year":"2020","journal-title":"Transl Lung Cancer Res."},{"key":"10.1016\/j.yexmp.2026.105091_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.fochx.2022.100225","article-title":"Capture and identification of bacteria from fish muscle based on immunomagnetic beads and MALDI-TOF MS","volume":"13","author":"Chai","year":"2022","journal-title":"Food Chem. X"},{"issue":"6991","key":"10.1016\/j.yexmp.2026.105091_bb0030","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/429496a","article-title":"Proteomics and cancer: running before we can walk?","volume":"429","author":"Check","year":"2004","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.yexmp.2026.105091_bb0035","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1128\/CMR.00072-12","article-title":"Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology","volume":"26","author":"Clark","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105091_bb0040","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1574-6976.2011.00298.x","article-title":"Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology","volume":"36","author":"Croxatto","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"issue":"6","key":"10.1016\/j.yexmp.2026.105091_bb0045","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced lung-Cancer mortality with volume CT screening in a randomized trial","volume":"382","author":"de Koning","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexmp.2026.105091_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/1746-1596-5-60","article-title":"Use of anchorchip-time-of-flight spectrometry technology to screen tumor biomarker proteins in serum for small cell lung cancer","volume":"5","author":"Du","year":"2010","journal-title":"Diagn. Pathol."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105091_bb0055","first-page":"1","article-title":"Biomarker discovery and identification from non-small cell lung cancer sera","volume":"3","author":"Du","year":"2011","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"10.1016\/j.yexmp.2026.105091_bb0060","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/985020","article-title":"Serum peptidome patterns of colorectal cancer based on magnetic bead separation and MALDI-TOF mass spectrometry analysis","volume":"2012","author":"Fan","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105091_bb0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1477-5956-1-2","article-title":"MALDI\/MS peptide mass fingerprinting for proteome analysis: identification of hydrophobic proteins attached to eucaryote keratinocyte cytoplasmic membrane using different matrices in concert","volume":"1","author":"Gonnet","year":"2003","journal-title":"Proteome Sci."},{"issue":"7","key":"10.1016\/j.yexmp.2026.105091_bb0070","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1470-2045(14)70162-7","article-title":"Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial","volume":"15","author":"Gregorc","year":"2014","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.yexmp.2026.105091_bb0075","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1309\/LMXWEJV3FFDR0DHH","article-title":"Discrimination analysis of mass spectrometry proteomics for lung adenocarcinoma detection","volume":"42","author":"Hong","year":"2011","journal-title":"Lab. Med."},{"key":"10.1016\/j.yexmp.2026.105091_bb0080","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8880034","article-title":"Urinary peptides associated closely with gestational diabetes mellitus","volume":"2020","author":"Hu","year":"2020","journal-title":"Dis. Markers"},{"issue":"4","key":"10.1016\/j.yexmp.2026.105091_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17040410","article-title":"Identification of serum peptidome signatures of non-small cell lung cancer","volume":"17","author":"Klupczynska","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.yexmp.2026.105091_bb0090","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/clinchem\/48.11.1931","article-title":"Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients","volume":"48","author":"Kulpa","year":"2002","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105091_bb0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1158\/0008-5472.CAN-17-0240","article-title":"Complement activation via a C3a receptor pathway alters CD4(+) T lymphocytes and mediates lung Cancer progression","volume":"78","author":"Kwak","year":"2018","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105091_bb0100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/joim.13480","article-title":"Low-dose computed tomography lung cancer screening: clinical evidence and implementation research","volume":"292","author":"Lancaster","year":"2022","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.yexmp.2026.105091_bb0105","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2013.13801","article-title":"Potentials and pitfalls of clinical peptidomics and metabolomics","volume":"143","author":"Leichtle","year":"2013","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.yexmp.2026.105091_bb0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-60327-047-2_4","article-title":"A novel approach using MALDI-TOF\/TOF mass spectrometry and prestructured sample supports (AnchorChip technology) for proteomic profiling and protein identification","volume":"441","author":"Leung","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.yexmp.2026.105091_bb0115","series-title":"Detection and significance of small-cell lung cancer serum protein markers using MALDI-TOF-MS2016","author":"Li","year":"2016"},{"issue":"1","key":"10.1016\/j.yexmp.2026.105091_bb0120","first-page":"34","article-title":"Detection of lung adenocarcinoma using magnetic beads based matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry serum protein profiling","volume":"123","author":"Lin","year":"2010","journal-title":"Chin. Med. J."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105091_bb0125","first-page":"51","article-title":"Exploratory study on application of MALDI-TOF-MS to detect serum and urine peptides related to small cell lung carcinoma","volume":"21","author":"Lv","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105091_bb0130","first-page":"363","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.yexmp.2026.105091_bb0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/1354750X.2012.657245","article-title":"Comparison of plasma from healthy nonsmokers, smokers, and lung cancer patients: pattern-based differentiation profiling of low molecular weight proteins and peptides by magnetic bead technology with MALDI-TOF MS","volume":"17","author":"Musharraf","year":"2012","journal-title":"Biomarkers"},{"issue":"21","key":"10.1016\/j.yexmp.2026.105091_bb0140","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1056\/NEJMoa1209120","article-title":"Results of initial low-dose computed tomographic screening for lung cancer","volume":"368","author":"National Lung Screening Trial Research T","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexmp.2026.105091_bb0145","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.yexmp.2026.105091_bb0150","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1039\/C8AN02241K","article-title":"MALDI-TOF MS-based total serum protein fingerprinting for liver cancer diagnosis","volume":"144","author":"Park","year":"2019","journal-title":"Analyst"},{"issue":"35","key":"10.1016\/j.yexmp.2026.105091_bb0155","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1200\/JCO.2007.13.5392","article-title":"Panel of serum biomarkers for the diagnosis of lung cancer","volume":"25","author":"Patz","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105091_bb0160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jamainternmed.2013.12738","article-title":"Overdiagnosis in low-dose computed tomography screening for lung cancer","volume":"174","author":"Patz","year":"2014","journal-title":"JAMA Intern. Med."},{"issue":"9306","key":"10.1016\/j.yexmp.2026.105091_bb0165","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(02)07746-2","article-title":"Use of proteomic patterns in serum to identify ovarian cancer","volume":"359","author":"Petricoin","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.yexmp.2026.105091_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-7-60","article-title":"Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer","volume":"7","author":"Pietrowska","year":"2009","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.yexmp.2026.105091_bb0175","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.2741\/3482","article-title":"Optimization of magnetic beads for maldi-TOF MS analysis","volume":"14","author":"Qiu","year":"2009","journal-title":"Front. Biosci. (Landmark Ed)"},{"issue":"13","key":"10.1016\/j.yexmp.2026.105091_bb0180","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1002\/pmic.200401245","article-title":"HUPO plasma proteome project specimen collection and handling: towards the standardization of parameters for plasma proteome samples","volume":"5","author":"Rai","year":"2005","journal-title":"Proteomics"},{"issue":"4","key":"10.1016\/j.yexmp.2026.105091_bb0185","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jnci\/dji054","article-title":"Lessons from controversy: ovarian cancer screening and serum proteomics","volume":"97","author":"Ransohoff","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.yexmp.2026.105091_bb0190","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002989","article-title":"Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancer","volume":"9","author":"Rich","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.yexmp.2026.105091_bb0195","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/321370","article-title":"Proteomics in cancer biomarkers discovery: challenges and applications","volume":"2015","author":"Sallam","year":"2015","journal-title":"Dis. Markers"},{"issue":"4","key":"10.1016\/j.yexmp.2026.105091_bb0200","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1255\/ejms.1080","article-title":"Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption\/ionization mass spectrometry","volume":"16","author":"Shevchenko","year":"2010","journal-title":"Eur J Mass Spectrom (Chichester)."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105091_bb0205","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.yexmp.2026.105091_bb0210","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1749-6632.2001.tb03525.x","article-title":"Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein","volume":"936","author":"Simpson-Haidaris","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.yexmp.2026.105091_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24254","article-title":"MALDI-TOF-MS analysis in low molecular weight serum peptidome biomarkers for NSCLC","volume":"36","author":"Song","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.yexmp.2026.105091_bb0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/1477-3163.107958","article-title":"Lung cancer biomarkers: state of the art","volume":"12","author":"Subramaniam","year":"2013","journal-title":"J. Carcinog."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105091_bb0225","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-017-3467-2","article-title":"MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer","volume":"17","author":"Swiatly","year":"2017","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.yexmp.2026.105091_bb0230","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/jnci\/djk195","article-title":"Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study","volume":"99","author":"Taguchi","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"issue":"13","key":"10.1016\/j.yexmp.2026.105091_bb0235","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1002\/pmic.200401219","article-title":"Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display","volume":"5","author":"Tammen","year":"2005","journal-title":"Proteomics"},{"issue":"6","key":"10.1016\/j.yexmp.2026.105091_bb0240","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jasms.2004.02.005","article-title":"Optimized sample-processing time and peptide recovery for the mass spectrometric analysis of protein digests","volume":"15","author":"Terry","year":"2004","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"Suppl. 1","key":"10.1016\/j.yexmp.2026.105091_bb0245","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/pmic.200700746","article-title":"Serum peptide profiling using MALDI mass spectrometry: avoiding the pitfalls of coated magnetic beads using well-established ZipTip technology","volume":"7","author":"Tiss","year":"2007","journal-title":"Proteomics"},{"issue":"2","key":"10.1016\/j.yexmp.2026.105091_bb0250","first-page":"135","article-title":"The American Cancer Society's facts & figures: 2020 edition","volume":"11","author":"Viale","year":"2020","journal-title":"J. Adv. Pract. Oncol."},{"issue":"3","key":"10.1016\/j.yexmp.2026.105091_bb0255","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1021\/ac504412p","article-title":"Sample preparation: a crucial factor for the analytical performance of rationally designed MALDI matrices","volume":"87","author":"Wiangnon","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.yexmp.2026.105091_bb0260","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.lungcan.2016.06.011","article-title":"Serum mass profile signature as a biomarker of early lung cancer","volume":"99","author":"Widlak","year":"2016","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.yexmp.2026.105091_bb0270","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jcla.21502","article-title":"Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC)","volume":"26","author":"Yang","year":"2012","journal-title":"J. Clin. Lab. Anal."},{"issue":"12","key":"10.1016\/j.yexmp.2026.105091_bb0265","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/ar.21267","article-title":"Serum peptidome profiling in patients with lung cancer","volume":"293","author":"Yang","year":"2010","journal-title":"Anat Rec (Hoboken)."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105091_bb0275","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1021\/pr060550h","article-title":"Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma","volume":"6","author":"Yi","year":"2007","journal-title":"J. Proteome Res."},{"issue":"10","key":"10.1016\/j.yexmp.2026.105091_bb0280","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/JTO.0b013e31814b8be7","article-title":"Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer","volume":"2","author":"Yildiz","year":"2007","journal-title":"J. Thorac. Oncol."},{"issue":"11","key":"10.1016\/j.yexmp.2026.105091_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9110155","article-title":"Current and prospective protein biomarkers of lung Cancer","volume":"9","author":"Zamay","year":"2017","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.yexmp.2026.105091_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27061925","article-title":"MALDI-TOF\/MS analysis of non-invasive human urine and saliva samples for the identification of new cancer biomarkers","volume":"27","author":"Zambonin","year":"2022","journal-title":"Molecules"},{"issue":"14","key":"10.1016\/j.yexmp.2026.105091_bb0295","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/pmic.200600184","article-title":"An improved method of sample preparation on AnchorChip targets for MALDI-MS and MS\/MS and its application in the liver proteome project","volume":"7","author":"Zhang","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.yexmp.2026.105091_bb0300","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2743060","article-title":"Study on the diagnosis of gastric cancer by magnetic beads extraction and mass spectrometry","volume":"2020","author":"Zhu","year":"2020","journal-title":"Biomed. Res. Int."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:23:29Z","timestamp":1793024609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480026000705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":60,"alternative-id":["S0014480026000705"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105091","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum peptidome signatures as diagnostic biomarkers of lung cancer: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105091"}}